Breaking News, Collaborations & Alliances

Quintiles To Help Launch Pharmaxis CF Drug

Bronchitol expected to launch in EU in 2011

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Quintiles has signed an agreement with Pharmaxis to provide a broad range of commercial solutions to support the European launch of Bronchitol, an innovative treatment for cystic fibrosis. Quintiles will execute a comprehensive commercialization effort for Bronchitol across western Europe. Beginning with Germany in early 2011, Quintiles will later support the commercialization of Bronchitol in France, Spain, Italy, Austria, Switzerland, the Netherlands, Belgium, Luxemburg and Portugal. Quinti...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters